Following a Standard TAVR Protocol Leads to Better Patient Outcomes
Following a Standard TAVR Protocol Leads to Better Patient Outcomes
Date: The article was highlighted on June 2, 2025
Source: JSCAI – Journal of the Society for Cardiovascular Angiography & Interventions
Key Takeaways :
1. What’s the Study About?
A global study looked at over 600 patients who received a TAVR valve between 2019 and 2023 at 50 hospitals. All patients received the Evolut PRO or PRO+ valve by Medtronic.
2. Why Is It Important?
When doctors followed a simple, step-by-step protocol during the procedure—especially using the Cusp Overlap Technique (COT)—patients had fewer complications, and fewer needed permanent pacemakers.
3. Better Results When the Protocol Was Followed:
• Death after 30 days: 0.8%
• Serious stroke: 1.7%
• Pacemaker need:
• 6.4% when protocol was followed
• 18.5% when it wasn’t
• Hospital stay: Average of 2 days
• Minimal valve leakage in most patients
4. Helpful Techniques:
• Using a specific guidewire (Lunderquist wire) also helped reduce complications.
5. Why It Matters:
The study showed that a standardized approach works in hospitals across different countries. It’s not complicated—but it makes a big difference in patient safety.
6. Quote from the Authors:
“When cardiologists stick to these essential steps, the results are consistent and much safer for patients.”
Bottom Line:
TAVR works best when done with care and consistency. This study proves that simple, unified protocols lead to better outcomes for heart patients around the world.
